Thyroid (USP) 15 MG Oral Tablet — RxCUI 314267
RxNorm drug concept · Semantic clinical drug
RxCUI 314267
Semantic clinical drug · SCD
● Current RxNorm concept 65 FDA products
96 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI314267
Official nameThyroid (USP) 15 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asthyroid (USP) 1/4 grain Oral Tablet; thyroid 15 MG (1/4 grain) Oral Tablet; levothyroxine sodium 9.5 MCG / liothyronine sodium 2.25 MCG Oral Tablet
FDA products mapped65
Package NDCs mapped96
Reported Medicaid activity (SDUD)228,962 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Thyroid: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. Desiccated thyroid — the active ingredient in products like Amerithroid and Thyroid Tablets — is made from dried pig (porcine) thyroid glands. It naturally contains...
- What exactly is desiccated thyroid, and is it different from the synthetic thyroid hormone my friend takes?
- It does matter a bit. Fasting actually increases the absorption of thyroid hormones, so many people take their tablet first thing in the morning, about 30–60 minutes before eating....
- Can I take my thyroid tablet with breakfast, or does it matter?
🕸️ Concept Web — How Thyroid (USP) 15 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Thyroid (USP) 15 MG Oral Tablet
RxCUI 314267 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Thyroid (USP)
10572IN
-
Thyroid (USP)
-
Brand names 7
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Adthyza
2671586BN -
Amerithroid
2743046BN -
Armour Thyroid
215407BN -
Evexithroid
2725182BN -
Niva Thyroid
2642811BN -
NP Thyroid
1724432BN -
Renthyroid
2706310BN
-
Adthyza
-
Dose forms 27
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Thyroid (USP) Oral Tablet
374122SCDF -
Thyroid (USP) Oral Product
1162082SCDG -
Thyroid (USP) Pill
1162083SCDG -
Thyroid (USP) Oral Tablet [Adthyza]
2671590SBDF -
Thyroid (USP) Oral Tablet [Amerithroid]
2743050SBDF -
Thyroid (USP) Oral Tablet [Armour Thyroid]
369234SBDF -
Thyroid (USP) Oral Tablet [Evexithroid]
2725186SBDF -
Thyroid (USP) Oral Tablet [Niva Thyroid]
2642815SBDF - +19 more in this family
-
Thyroid (USP) Oral Tablet
-
Clinical & branded drugs 15
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Thyroid (USP) 15 MG
316823SCDC -
Thyroid (USP) 15 MG Oral Tablet [Adthyza]
2671591SBD -
Thyroid (USP) 15 MG Oral Tablet [Amerithroid]
2743053SBD -
Thyroid (USP) 15 MG Oral Tablet [Armour Thyroid]
208534SBD -
Thyroid (USP) 15 MG Oral Tablet [Evexithroid]
2725187SBD -
Thyroid (USP) 15 MG Oral Tablet [Niva Thyroid]
2642818SBD -
Thyroid (USP) 15 MG Oral Tablet [NP Thyroid]
1855086SBD -
Thyroid (USP) 15 MG Oral Tablet [Renthyroid]
2706333SBD - +7 more in this family
-
Thyroid (USP) 15 MG
Showing up to 8 concepts per family — 24 of 50 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Thyroid (USP) 15 MG
SCDC · 316823 -
Thyroid (USP) Oral Tablet
SCDF · 374122 -
Thyroid (USP) Oral Product
SCDG · 1162082 -
Thyroid (USP) Pill
SCDG · 1162083
Brand-Name Concepts
-
Thyroid (USP) 15 MG Oral Tablet [Amerithroid]
SBD · 2743053 -
Thyroid (USP) 15 MG Oral Tablet [Armour Thyroid]
SBD · 208534 -
Thyroid (USP) 15 MG Oral Tablet [Evexithroid]
SBD · 2725187 -
Thyroid (USP) 15 MG Oral Tablet [Niva Thyroid]
SBD · 2642818 -
Thyroid (USP) 15 MG Oral Tablet [NP Thyroid]
SBD · 1855086 -
Thyroid (USP) 15 MG Oral Tablet [Renthyroid]
SBD · 2706333 -
Thyroid (USP) 15 MG Oral Tablet [Adthyza]
SBD · 2671591 -
Thyroid (USP) 15 MG [Adthyza]
SBDC · 2671587 -
Thyroid (USP) 15 MG [Amerithroid]
SBDC · 2743052 -
Thyroid (USP) 15 MG [Armour Thyroid]
SBDC · 569213
📦 FDA Products & Package NDCs
65 products · 96 package NDCs
96 package NDCs map to RxCUI 314267 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 64950-0175-01 | 100 TABLET in 1 BOTTLE (64950-175-01) | RenThyroid | Genus Lifesciences | 2025-03-01 |
| 64950-0175-09 | 90 TABLET in 1 BOTTLE (64950-175-09) | RenThyroid | Genus Lifesciences | 2025-03-01 |
| 64950-0179-01 | 100 TABLET in 1 BOTTLE (64950-179-01) | RenThyroid | Genus Lifesciences | 2025-03-01 |
| 64950-0179-09 | 90 TABLET in 1 BOTTLE (64950-179-09) | RenThyroid | Genus Lifesciences | 2025-03-01 |
| 64950-0179-14 | 14 TABLET in 1 BOTTLE (64950-179-14) | RenThyroid | Genus Lifesciences | 2025-03-01 |
| 64950-0180-01 | 100 TABLET in 1 BOTTLE (64950-180-01) | RenThyroid | Genus Lifesciences | 2025-03-01 |
| 64950-0180-09 | 90 TABLET in 1 BOTTLE (64950-180-09) | RenThyroid | Genus Lifesciences | 2025-03-01 |
| 64950-0180-14 | 14 TABLET in 1 BOTTLE (64950-180-14) | RenThyroid | Genus Lifesciences | 2025-03-01 |
| 69680-0165-00 | 100 TABLET in 1 BOTTLE (69680-165-00) | Thyroid | Vitruvias Therapeutics | 2024-11-22 |
| 69680-0166-00 | 100 TABLET in 1 BOTTLE (69680-166-00) | Thyroid | Vitruvias Therapeutics | 2024-11-22 |
| 69680-0167-00 | 100 TABLET in 1 BOTTLE (69680-167-00) | Thyroid | Vitruvias Therapeutics | 2024-11-22 |
| 69680-0168-00 | 100 TABLET in 1 BOTTLE (69680-168-00) | Thyroid | Vitruvias Therapeutics | 2024-11-22 |
| 69680-0169-00 | 100 TABLET in 1 BOTTLE (69680-169-00) | Thyroid | Vitruvias Therapeutics | 2024-11-22 |
| 73352-0693-10 | 100 TABLET in 1 BOTTLE (73352-693-10) | EvexiTHROID | Trifluent Pharma, LLC | 2025-10-12 |
| 73352-0694-10 | 100 TABLET in 1 BOTTLE (73352-694-10) | EvexiTHROID | Trifluent Pharma, LLC | 2025-10-12 |
| 73352-0695-10 | 100 TABLET in 1 BOTTLE (73352-695-10) | EvexiTHROID | Trifluent Pharma, LLC | 2025-10-12 |
| 73352-0696-10 | 100 TABLET in 1 BOTTLE (73352-696-10) | EvexiTHROID | Trifluent Pharma, LLC | 2025-10-12 |
| 73352-0697-10 | 100 TABLET in 1 BOTTLE (73352-697-10) | EvexiTHROID | Trifluent Pharma, LLC | 2025-10-12 |
| 73352-0698-10 | 100 TABLET in 1 BOTTLE (73352-698-10) | EvexiTHROID | Trifluent Pharma, LLC | 2025-10-12 |
| 73352-0699-10 | 100 TABLET in 1 BOTTLE (73352-699-10) | EvexiTHROID | Trifluent Pharma, LLC | 2025-10-12 |
| 73352-0700-10 | 100 TABLET in 1 BOTTLE (73352-700-10) | EvexiTHROID | Trifluent Pharma, LLC | 2025-10-12 |
| 75834-0310-01 | 100 TABLET in 1 BOTTLE (75834-310-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0311-01 | 100 TABLET in 1 BOTTLE (75834-311-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0312-01 | 100 TABLET in 1 BOTTLE (75834-312-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0313-01 | 100 TABLET in 1 BOTTLE (75834-313-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0314-01 | 100 TABLET in 1 BOTTLE (75834-314-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0315-01 | 100 TABLET in 1 BOTTLE (75834-315-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0316-01 | 100 TABLET in 1 BOTTLE (75834-316-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 75834-0317-01 | 100 TABLET in 1 BOTTLE (75834-317-01) | Niva Thyroid | Nivagen Pharmaceuticals, Inc. | 2023-07-24 |
| 76420-0566-01 | 100 TABLET in 1 BOTTLE (76420-566-01) | NP Thyroid 15 | Asclemed USA, Inc. | 2023-05-12 |
| 76420-0566-30 | 30 TABLET in 1 BOTTLE (76420-566-30) | NP Thyroid 15 | Asclemed USA, Inc. | 2023-05-12 |
| 76420-0566-60 | 60 TABLET in 1 BOTTLE (76420-566-60) | NP Thyroid 15 | Asclemed USA, Inc. | 2023-05-12 |
| 76420-0566-90 | 90 TABLET in 1 BOTTLE (76420-566-90) | NP Thyroid 15 | Asclemed USA, Inc. | 2023-05-12 |
| 79739-7370-01 | 100 TABLET in 1 BOTTLE (79739-7370-1) | Thyroid | LGM PHARMA SOLUTIONS, LLC | 2025-01-02 |
| 79739-7371-01 | 100 TABLET in 1 BOTTLE (79739-7371-1) | Thyroid | LGM PHARMA SOLUTIONS, LLC | 2025-01-02 |
| 79739-7372-01 | 100 TABLET in 1 BOTTLE (79739-7372-1) | Thyroid | LGM PHARMA SOLUTIONS, LLC | 2025-01-02 |
| 79739-7373-01 | 100 TABLET in 1 BOTTLE (79739-7373-1) | Thyroid | LGM PHARMA SOLUTIONS, LLC | 2025-01-02 |
| 79739-7374-01 | 100 TABLET in 1 BOTTLE (79739-7374-1) | Thyroid | LGM PHARMA SOLUTIONS, LLC | 2025-01-02 |
| 82685-0341-01 | 100 TABLET in 1 BOTTLE (82685-341-01) | Amerithroid | Oliva Therapeutics, LLC | 2026-05-07 |
| 82685-0342-01 | 100 TABLET in 1 BOTTLE (82685-342-01) | Amerithroid | Oliva Therapeutics, LLC | 2026-05-07 |
| 82685-0343-01 | 100 TABLET in 1 BOTTLE (82685-343-01) | Amerithroid | Oliva Therapeutics, LLC | 2026-05-07 |
| 82685-0344-01 | 100 TABLET in 1 BOTTLE (82685-344-01) | Amerithroid | Oliva Therapeutics, LLC | 2026-05-07 |
| 82685-0345-01 | 100 TABLET in 1 BOTTLE (82685-345-01) | Amerithroid | Oliva Therapeutics, LLC | 2026-05-07 |
| 82685-0346-01 | 100 TABLET in 1 BOTTLE (82685-346-01) | Amerithroid | Oliva Therapeutics, LLC | 2026-05-07 |
| 82685-0347-01 | 100 TABLET in 1 BOTTLE (82685-347-01) | Amerithroid | Oliva Therapeutics, LLC | 2026-05-07 |
| 82685-0348-01 | 100 TABLET in 1 BOTTLE (82685-348-01) | Amerithroid | Oliva Therapeutics, LLC | 2026-05-07 |
Observed labelers:
Genus Lifesciences (23) ·
Acella Pharmaceuticals, LLC (18) ·
Allergan, Inc. (9) ·
Nivagen Pharmaceuticals, Inc. (8) ·
Oliva Therapeutics, LLC (8) ·
Trifluent Pharma, LLC (8)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.